Cancer-Associated Hypercalcemia

N Engl J Med. 2022 Apr 14;386(15):1443-1451. doi: 10.1056/NEJMcp2113128.

Authors

Theresa A Guise¹, John J Wysolmerski¹

Affiliation

¹ From the Section of Bone and Mineral Disorders, Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M.D. Anderson Cancer Center, and the Lawrence Bone Disease Program of Texas, Houston, and the Cancer Prevention Research Institute of Texas, Austin (T.A.G.); and the Section of Endocrinology and Metabolism, Department of Medicine, Yale School of Medicine, New Haven, CT (J.J.W.).

PMID: 35417639
DOI: 10.1056/NEJMcp2113128

No abstract available

Publication types

Review

MeSH terms

Carcinoma, Squamous Cell / complications
Humans
Hypercalcemia* / etiology
Neoplasms* / complications
Paraneoplastic Syndromes* / complications

Supplementary concepts

Humoral Hypercalcemia Of Malignancy

Grants and funding